gb ONCO JAK2 (V617F)
quantitative real-time PCR
The kit is used for detection and quantification of somatic mutation V617F JAK2 gene in human genomic DNA. The detection principle is based on real-time PCR using fluorescently labeled probes and allele specific primers.
The JAK2 enzyme is involved in the signaling pathway leading to blood cell production. Substitution of the amino acid valine for phenylalanine at position 617 leads to uncontrolled cell proliferation and survival of hematopoietic precursors. Somatic mutation occurs in most patients with with diseases such as essential thrombocythemia and chronic idiopathic myelofibrosis.
A higher risk of complications (thrombosis, abortion, etc.) is generally expected in carriers of this mutation.
Parameters of the diagnostic kit
- ready-to-use assay
- LOD 0.1% mutated JAK2 on WT background at 100,000 copies in reaction
- sample concentration 4-80 ng/µl
- positive and negative controls included
- FAM channel detection
- identical amplification profile as gb HEMO, gb GENETIC, gb PHARM kits
1 kit contains reagents to provide 25 or 50 PCR reactions (25 μl volume of each reaction).
Selling, offering, storage and usage of the product in some countries may infringe valid patent rights under patent EP 1692281 and its equivalents.